logo

IMVT

Immunovant·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-28
7.02 / 10Overall Score
OutperformInvestment Rating
FundamentalSentimentTechnical
Should I Buy IMVT Now?
  • Based on a composite score of 7.02/10, we rate IMVT as a Outperform. Our analysis breaks down into 9.14/10 for Fundamentals, 4.90/10 for Technicals, and 7.02/10 for Sentiment, indicating the stock is likely to See further upside.
Is IMVT fundamentally strong?
What is the current technical signals for IMVT?
What is the market sentiment for IMVT?